Funding Details
- Awarder
- Inbox
- Date Award
- February 01, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$60,000,000
Company Info
- Company Description
- Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
- Market
- Gene Therapy
- Location
-
Cambridge,
MA,
USA
- Coinvestors
- Aisling Capital, Atlas Venture, Brace Pharma, Clarus Ventures, Cormorant Asset Management, Eventide Asset Management, Morningside Venture, Surveyor Capital, SV Health Investors
Links